These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32204916)

  • 1. Protease-activated receptor 2 deficiency in hematopoietic lineage protects against myocardial infarction through attenuated inflammatory response and fibrosis.
    Zuo P; Zhu Y; Li Y; Zuo Z; Sheng Z; Yan G; Ma G
    Biochem Biophys Res Commun; 2020 May; 526(1):253-260. PubMed ID: 32204916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.
    Friebel J; Weithauser A; Witkowski M; Rauch BH; Savvatis K; Dörner A; Tabaraie T; Kasner M; Moos V; Bösel D; Gotthardt M; Radke MH; Wegner M; Bobbert P; Lassner D; Tschöpe C; Schutheiss HP; Felix SB; Landmesser U; Rauch U
    Eur Heart J; 2019 Oct; 40(40):3318-3332. PubMed ID: 31004144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
    Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
    Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A9 Links Inflammation and Repair in Myocardial Infarction.
    Marinković G; Koenis DS; de Camp L; Jablonowski R; Graber N; de Waard V; de Vries CJ; Goncalves I; Nilsson J; Jovinge S; Schiopu A
    Circ Res; 2020 Aug; 127(5):664-676. PubMed ID: 32434457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
    Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ
    Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
    Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
    Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
    de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
    Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.
    Kimura T; Tajiri K; Sato A; Sakai S; Wang Z; Yoshida T; Uede T; Hiroe M; Aonuma K; Ieda M; Imanaka-Yoshida K
    Cardiovasc Res; 2019 Mar; 115(3):614-624. PubMed ID: 30295707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice.
    Gunther RC; Bharathi V; Miles SD; Tumey LR; Schmedes CM; Tatsumi K; Bridges MD; Martinez D; Montgomery SA; Beck MA; Camerer E; Mackman N; Antoniak S
    Front Immunol; 2021; 12():791017. PubMed ID: 34925374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.
    Liu J; Nishida M; Inui H; Chang J; Zhu Y; Kanno K; Matsuda H; Sairyo M; Okada T; Nakaoka H; Ohama T; Masuda D; Koseki M; Yamashita S; Sakata Y
    J Atheroscler Thromb; 2019 Oct; 26(10):915-930. PubMed ID: 30867376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PAR2 in murine pulmonary pseudomonal infection.
    Moraes TJ; Martin R; Plumb JD; Vachon E; Cameron CM; Danesh A; Kelvin DJ; Ruf W; Downey GP
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L368-77. PubMed ID: 18083764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin protects against the development of systolic dysfunction following myocardial infarction.
    Shibata R; Izumiya Y; Sato K; Papanicolaou K; Kihara S; Colucci WS; Sam F; Ouchi N; Walsh K
    J Mol Cell Cardiol; 2007 Jun; 42(6):1065-74. PubMed ID: 17499764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
    Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAIR-II deficiency ameliorates cardiac remodelling post-myocardial infarction by suppressing TLR9-mediated macrophage activation.
    Yonebayashi S; Tajiri K; Murakoshi N; Xu D; Li S; Feng D; Okabe Y; Yuan Z; Song Z; Aonuma K; Shibuya A; Aonuma K; Ieda M
    J Cell Mol Med; 2020 Dec; 24(24):14481-14490. PubMed ID: 33140535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction.
    Schumacher D; Alampour-Rajabi S; Ponomariov V; Curaj A; Wu Z; Staudt M; Rusu M; Jankowski V; Marx N; Jankowski J; Brandenburg V; Liehn EA; Schuh A
    Cardiovasc Pathol; 2019; 40():47-54. PubMed ID: 30852297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury.
    Yue Y; Huang S; Wang L; Wu Z; Liang M; Li H; Lv L; Li W; Wu Z
    Circ J; 2020 Mar; 84(4):626-635. PubMed ID: 32161201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
    Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.
    Trial J; Heredia CP; Taffet GE; Entman ML; Cieslik KA
    Basic Res Cardiol; 2017 Jul; 112(4):34. PubMed ID: 28478479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.